Approval · Notice of Compliance 36320 · 2025
ANTHIM: Notice of Compliance 36320
Issued November 4, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36320
- Date
- November 4, 2025
- Company
- Elusys Therapeutics IncBoca Raton, Florida, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Drug substance manufacturing process change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANTHIM | Not yet assigned | — |
Medicinal ingredients
- OBILTOXAXIMAB 100 MG per ML